Clinical Trials Sponsored by Mylan Germany GmbH

Total 284 results

Mylan Inc.
Mylan Österreich GmbH; Mylan Germany GmbH; Mylan Healthcare Sp. z o.o.

Completed

Observation of the Effects of Guideline-driven Lifestyle Interventions, Including Use of a Red-yeast Based Nutraceutical

Hypercholesterolemia

Germany, Austria
Mylan Inc.
Mylan GmbH

Completed

Phase I - Pharmacokinetic Comparability Study in Healthy Male Volunteers

Healthy

Netherlands
Mylan Inc.
Mylan GmbH

Completed

Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients

Type 1 Diabetes Mellitus

Czechia, United States, Canada, Estonia, Germany, Hungary, Latvia, Slovakia
Mylan Inc.
Mylan GmbH

Completed

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1) (INSTRIDE 1)

Type 1 Diabetes

United States, Canada, Czechia, Estonia, Germany, Hungary, Latvia, Romania, Slovakia, South Africa, United Kingdom
Mylan Inc.
Mylan GmbH

Completed

Study of Efficacy and Safety of Myl1401O + Taxane vs Herceptin©+ Taxane for 1st Line, Met. Br. Ca. (HERiTAge)

Breast Cancer

Slovakia, Brazil, Chile, Georgia, Hungary, India, Latvia, Peru, Romania, Russian Federation, Serbia, South Africa, Thailand, Turkey, Ukraine
Mylan Inc.
Mylan GmbH

Completed

MYL-1401A Efficacy and Safety Comparability Study to Humira®

Psoriasis | Arthritis, Psoriatic

Bulgaria, Estonia, Hungary, Poland, Russian Federation, Ukraine
Mylan Inc.
Mylan GmbH

Completed

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2) (INSTRIDE 2)

Type 2 Diabetes

United States, Jordan, Korea, Republic of, Slovakia, South Africa, Taiwan
Mylan Inc.
Mylan GmbH

Completed

Mylan Insulin Glargine Study

Diabetes Mellitus, Type 1

United States
Mylan Inc.
Mylan GmbH

Completed

Mylan Insulin Aspart Study

Diabetes Mellitus, Type 1

United States
Mylan Inc.
Mylan GmbH

Completed

Adalimumab PK Bioequivalence Study to EU and US Sourced Humira

Healthy Volunteers

Belgium
Mylan Inc.
Mylan GmbH

Completed

Efficacy and Safety Study With MYL-1401H and Neulasta

Breast Neoplasms | Chemotherapy-Induced Febrile Neutropenia

Bulgaria, Georgia, Germany, Hungary, Poland, Ukraine
Mylan Inc.
Mylan GmbH

Completed

Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta

Healthy Volunteers

Netherlands
Mylan Pharmaceuticals Inc
Mylan GmbH

Completed

Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion

Healthy
AIO-Studien-gGmbH
Merck Serono GmbH, Germany

Terminated

Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract Cancer (NEOBIL)

Cholangiocarcinoma | Biliary Tract Cancer

Germany
Charite University, Berlin, Germany
German Research Foundation; adexter GmbH

Completed

Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)

Septicemia

Germany
Mylan Inc.
inVentiv Health Germany GmbH; EBC - Evidence Based Communication

Completed

Omacor Plus Standard Therapies In Post Myocardial Infarction (MI) Subjects Evaluation: The OPTIMISE Observational Study

Myocardial Infarction (MI)

Bulgaria
AbbVie
IST GmbH, Germany

Completed

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary (VERITAS)

Chronic Hepatitis C
AbbVie
IST GmbH, Germany

Completed

Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium

Chronic Hepatitis C, Genotype 1 or 4
AbbVie
IST GmbH, Germany

Completed

Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania

Chronic Hepatitis C
AbbVie
IST GmbH, Germany

Completed

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C

Chronic Hepatitis C
Universitätsklinikum Hamburg-Eppendorf
Federal Joint Committee; aQua-Institut GmbH, Germany; Leibniz-Institut für Resilienzforschung... and other collaborators

Active, not recruiting

Family Health Partners in Regional Network Structures (NEST)

Disabled or Chronically Ill Children in Need of Care

Germany
Charite University, Berlin, Germany
Novartis Germany GmbH

Completed

Evaluation of Sloan-Charts for Assessment of Disease Progress in Multiple Sclerosis

Multiple Sclerosis

Germany
Merck KGaA, Darmstadt, Germany
Merck Serono GmbH, Germany

Completed

Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone) (LODOTRA)

Arthritis, Rheumatoid

Germany
AbbVie
Hannover Medical School; IST GmbH, Germany; Improvement by Movement GmbH, Germany

Terminated

A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment (STRIKE)

Axial Spondyloarthritis
Merck KGaA, Darmstadt, Germany
Merck Serono GmbH, Germany

Completed

To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

Infertility | Ovulation Induction
Sanofi
Profil GmbH, Neuss, Germany

Completed

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2 (RESTORE)

Diabetes Mellitus, Type 2

Germany
Shire
Nycomed Germany GmbH

Completed

Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

Short Bowel Syndrome

Spain, United States, Canada, France, Denmark, Poland, Germany, Italy, United Kingdom
AIO-Studien-gGmbH
Universitätsklinikum Hamburg-Eppendorf; Merck Serono GmbH, Germany; Pierre Fabre...

Recruiting

Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer (NeoBRAF)

Colorectal Cancer | Colon Cancer | BRAF V600 Mutation | BRAF V600E | Localized Cancer

Germany
Mylan Inc.
Winicker Norimed GmbH

Terminated

REVIparin-BRIDging-in a General Practice Setting in GErmany (REVIBRIDGE)

Thromboembolism

Germany
Charite University, Berlin, Germany
Pfrimmer Nutricia GmbH, Erlangen , Germany

Completed

Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors

Colorectal Neoplasms | Hepatocellular Carcinoma | Cholangiocarcinoma

Germany
Charite University, Berlin, Germany
Pfrimmer Nutricia GmbH, Erlangen , Germany

Completed

Medical and Health Economic Benefit of Oral Nutritional Supplements (ONS) in Ambulant Patients (ECONONS)

Malnutrition

Germany
Fresenius Medical Care Deutschland GmbH
Siro Clinpharm Germany GmbH

Completed

Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) (Steering)

ESRD | Hyperphosphataemia

United Kingdom, Spain, Denmark, Germany
Charite University, Berlin, Germany
ribosepharm GmbH

Unknown

Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)

Recurrent Small Cell Lung Cancer

Germany
Charite University, Berlin, Germany
HeVaTech GmbH

Completed

Pulsatile Cupping in Low Back Pain (Cupping-LBP)

Chronic Low Back Pain

Germany
AbbVie
Cato Research; IST GmbH, Germany

Completed

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada (AMBER)

Chronic Hepatitis C
DiaNe HCM GmbH
Roche Pharma Deutschland GmbH, Grenzach-Wyhlen, Germany; Institute for Medical...

Completed

Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy (DiaNe)

Diabetic Nephropathy

Germany
Follicum AB
proDERM GmbH; Hair and Skin Institute, Charité, Berlin, Germany; Centroderm GmbH...

Completed

A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers

Androgenetic Alopecia

Germany
University of Ulm
Medac GmbH (Hamburg, Germany); Roche (Grenzach-Wyhlen, Germany)

Completed

Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer (FOGT1)

Rectal Cancer

Germany
Charite University, Berlin, Germany
Sanofi; Proinnovera GmbH

Completed

Cholinergic Urticaria - Efficacy of Dupilumab (CHED)

Cholinergic Urticaria

Germany
University of Southern Denmark
SignaTope GmbH, Germany

Completed

Flucloxacillin as an Inducer of CYP-enzymes

Healthy Volunteers | Drug Drug Interaction

Denmark
Charite University, Berlin, Germany
Essex Pharma GmbH

Completed

Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU) (AUD2OCU)

Chronic Urticaria

Germany
Provitro GmbH
Charite University, Berlin, Germany; AstraZeneca

Completed

Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC

Mutations in Exons 18 to 21

Germany
Charite University, Berlin, Germany
Seibersdorf Labor GmbH

Suspended

Effects of WiFi Exposure on Sleep in Women

Sleep

Germany
Charite University, Berlin, Germany
Shire International GmbH

Active, not recruiting

Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS) (LANA-FXII)

Hereditary Autoinflammatory Disease

Germany
Medtronic Bakken Research Center
Medtronic GmbH Germany

Completed

Protecta Smart Analysis Register (ProSA)

Patients With an Indication for an ICD Implantation According to the Guidelines
Charite University, Berlin, Germany
Sysmex Europe GmbH

Completed

Hematological Infection Score Compared to the Hospital Standard for Diagnosis of SIRS or Sepsis on ICU

Sepsis | SIRS

Germany
Charite University, Berlin, Germany
Johnson & Johnson GmbH

Completed

Clinical Analysis of the Influence of Using the Skin Care Products on the Diaper Area in Comparison With Using a Cotton Wool Cloth, Moistened With Clear Water on the Skin Physiology of the Newborns From the 1st Day to the 4th Week of Life

Postnatal Skin Physiology
Charite University, Berlin, Germany
Reactive Robotics GmbH

Completed

Robotic Assisted Early Mobilization in Ventilated ICU Patients (ROBEM-I)

Critical Illness | Rehabilitation | Early Ambulation | Critical Illness Polyneuromyopathy

Germany
Charite University, Berlin, Germany
Reactive Robotics GmbH

Completed

Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19

Critical Illness | Covid19 | Rehabilitation | Robotics | Early Mobilization | Critical Illness Polyneuromyopathy

Germany
Vaximm GmbH
Pfizer; Merck KGaA, Darmstadt, Germany

Active, not recruiting

VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma

Recurrent Glioblastoma

Germany

Clinical Trials Sponsored by Mylan Germany GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations